4-[4-氨基-5-氯-2-甲氧基苯胺]-1-苄基哌啶马来酸盐

Intern. Med. 47(6) , 551-2, (2008)

We present a 21-year-old woman with an oculogyric crisis following the administration of clebopride. Based on the temporal relationship of the administration of clebopride to the occurrence of the event and the absence of other possible etiologies, clebopride...

Clin. Neuropharmacol. 32(2) , 107-8, (2009)

Dystonic reactions produce twisting and repetitive movements or abnormal posturing. Severe dystonic reactions have been shown to occur in concert with numerous medications. This report details the case of a patient who developed hemifacial dystonia as acute s...

Rev. Esp. Enferm. Dig. 103(3) , 161-2, (2011)

Bull. Exp. Biol. Med. 150(3) , 281-5, (2011)

Administration of D(2) receptor antagonist clebopride in a dose not affecting locomotor activity was followed by a decrease in maternal bonding behavior of 10-day-old and 15-day-old albino rat pups. D(1) receptor antagonist SCH23390 had a stimulatory effect o...

Bull. Exp. Biol. Med. 153(2) , 182-5, (2012)

This study examined the effect of clebopride at low concentration that did not modify the motor activity on the parental care in female albino rats. Single injection of the drug attenuated the parental care reactions on postinjection minute 20, but not one da...

Zh. Vyssh. Nerv. Deiat. Im. I P Pavlova 60(2) , 247-54, (2010)

A new method of studying "child's" (maternal bonding) behavior of newborn rats was developed. The efficiency of the method was proved in estimation of dopaminergic control of the infant-mother attachment. Selective D2-antagonist clebopride applied in subthres...

Rev. Neurol. 25(148) , 2060, (1997)

Eur. J. Neurol. 19(6) , e59, (2012)

Mov. Disord 21(9) , 1536, (2006)

Med. Clin. (Barc.) 121(1) , 38-9, (2003)